FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

American Regent niCARdipine Hydrochloride Injection Recall

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2

American Regent, Inc. · New Albany, OH

Risk level
Class II
Reported by FDA
May 7, 2025
Recall ID
D-0399-2025
Check your lot numberHow we source this data

Summary

American Regent recalled niCARdipine Hydrochloride Injection starting Apr 18, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0399-2025 on May 7, 2025. Reason: Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. Status: Ongoing.

Why it was recalled

Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.

Product description

niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]

Lot numbers, UPCs & expiration codes

Lots, expiry: Lot 24086N0C0, 7/31/2025; Lot 24076N0C0, Lot 24090N0C0, 8/31/2025, Lot 25011N0C0, 6/30/2026;

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0399-2025
Classification
Class II
Status
Ongoing
Recall initiated
Apr 18, 2025
FDA report date
May 7, 2025
Quantity
7,249 (cartons of 10 x 10 mL vials)
Recall type
Voluntary: Firm initiated
Recalling firm
American Regent, Inc.

Original FDA data

Every field from FDA enforcement report D-0399-2025, exactly as published.

Show all FDA fields
City
New Albany
State
OH
Status
Ongoing
Country
United States
Event ID
96695
Address
6610 New Albany Rd E
Code information
Lots, expiry: Lot 24086N0C0, 7/31/2025; Lot 24076N0C0, Lot 24090N0C0, 8/31/2025, Lot 25011N0C0, 6/30/2026;
Postal code
43054-8730
Report date
May 7, 2025
Product type
Drugs
Recall number
D-0399-2025
Classification
Class II
Recalling firm
American Regent, Inc.
Product quantity
7,249 (cartons of 10 x 10 mL vials)
Reason for recall
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC carton: 0517-0735-10 / NDC Vial: 0517-0735-01]
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 18, 2025
Initial firm notification
Letter
Center classification date
May 1, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0399-2025, published May 7, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls